Citation:Peeters M, Oliner KS, Price TJ, Cervantes A, Sobrero AF, Ducreux M, et al 2015

Citation

Peeters M, Oliner KS, Price TJ, Cervantes A, Sobrero AF, Ducreux M, et al. Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer. Clin Cancer Res 2015 Dec 15;21(24):5469-79 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26341920.

Critical appraisals

• Assign a critical appraisal

Cited by

1. Molecular pathology and biomarkers – implications for systemic therapy